bioRxiv Science⌕ Search

Biology subjects

Blin, J.

Publications and source records attributed to Blin, J..

3 recordsLinked to original sources

Convergent transcriptomic and genomic adaptation in xeric rodents

Repeated adaptations rely in part on convergent genetic changes. The extent of convergent changes at the genomic scale is debated and may depend on the interplay between different factors. Rodents have repeatedly adapted to life in arid conditions, notably with altered renal morphology and physiology. This occurred at different time periods, allowing us to test the importance of time in convergent genomic evolution. We analyzed kidney transcriptomes from 34 species to quantify and characterize convergent evolution at the level of gene expression, tissue composition, and coding sequences. We found that several genes showed convergent expression changes, some of which also carried convergent changes in their coding sequence. We then subdivided these data to test the influence of evolutionary history. First, within the subfamily Murinae, we found more convergent gene expression, reflecting convergent changes in cell proportions. Second, we compared data for recent (within genera) and ancient (between genera) adaptations, and observed more convergent changes in the latter. Our study shows that adaptation to xeric environments in rodents involves repeated changes in tissue composition, gene expression and coding sequences, and that the degree of convergent evolution increases with both the age of the adaptations and species relatedness.

evolutionary biology↗

Global ribosome profiling reveals that mutant huntingtin stalls ribosomes and represses protein synthesis independent of fragile X mental retardation protein

The regulators that stall ribosome translocation are poorly understood. We find that polyglutamine-expanded mutant Huntingtin (mHtt), the Huntingtons disease (HD) causing protein, promotes ribosome stalling and physiologically suppresses protein synthesis. A comprehensive, genome-wide analysis of ribosome footprint profiling (Ribo-Seq) revealed widespread ribosome stalling on mRNA transcripts and a shift in the distribution of ribosomes toward the 5 end, with single-codon unique pauses on selected mRNAs in HD cells. In Ribo-Seq, we found fragile X mental retardation protein (FMRP), a known regulator of ribosome stalling, translationally upregulated and it co-immunoprecipitated with mHtt in HD cells and postmortem brain. Depletion of FMRP gene, Fmr1, however, did not affect the mHtt-mediated suppression of protein synthesis or ribosome stalling in HD cells. Consistent with this, heterozygous deletion of Fmr1 in Q175FDN-Het mouse model, Q175FDN-Het; Fmr1+/-, showed no discernable phenotype, but a subtle deficit in motor skill learning. On the other hand, depletion of mHtt, which binds directly to ribosomes in an RNase-sensitive manner, enhanced global protein synthesis, increased ribosome translocation and decreased stalling. This mechanistic knowledge advances our understanding of the inhibitory role of mHtt in ribosome translocation and may lead to novel target(s) identification and therapeutic approaches that modulate ribosome stalling in HD.\n\nOne Sentence SummaryHuntingtons disease (HD) protein, mHtt, binds to ribosomes and affects their translocation and promotes stalling independent of the fragile X mental retardation protein.

neuroscience↗

Efficient genome editing in primary cells and in vivo using viral-derived "Nanoblades" loaded with Cas9/sgRNA ribonucleoproteins

Programmable nucleases have enabled rapid and accessible genome engineering in eukaryotic cells and living organisms. However, their delivery into target cells can be technically challenging when working with primary cells or in vivo. Using engineered murine leukemia virus-like particles loaded with Cas9/sgRNA ribonucleoproteins (\"Nanoblades\"), we were able to induce efficient genome-editing in cell lines and primary cells including human induced pluripotent stem cells, human hematopoietic stem cells and mouse bone-marrow cells. Transgene-free Nanoblades were also capable of in vivo genome-editing in mouse embryos and in the liver of injected mice. Nanoblades can be complexed with donor DNA for \"all-in-one\" homology-directed repair or programmed with modified Cas9 variants to mediate transcriptional up-regulation of target genes. Nanoblades preparation process is simple, relatively inexpensive and can be easily implemented in any laboratory equipped for cellular biology.

cell biology↗